Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of the International AIDS Society
Published in: Journal of the International AIDS Society 4/2010

Open Access 01-12-2010 | Poster presentation

Haemoglobin and anaemia in the SMART study

Authors: A Mocroft, AR Lifson, G Touloumi, J Neuhaus, Z Fox, A Palfreeman, M Vjecha, S Hodder, S De Wit, JD Lundgren, AN Phillips

Published in: Journal of the International AIDS Society | Special Issue 4/2010

Login to get access

Excerpt

Data from randomized trials on the development of anaemia after interruption of therapy is not well described. We aimed to describe the development of anaemia after interruption of cART and the relationship between the development of anaemia and clinical events (AIDS, deaths or non-AIDS events) in the Strategic Management of Antiretroviral Therapy (SMART) randomised trial. …
Metadata
Title
Haemoglobin and anaemia in the SMART study
Authors
A Mocroft
AR Lifson
G Touloumi
J Neuhaus
Z Fox
A Palfreeman
M Vjecha
S Hodder
S De Wit
JD Lundgren
AN Phillips
Publication date
01-12-2010
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1758-2652-13-S4-P144

Other articles of this Special Issue 4/2010

Journal of the International AIDS Society 4/2010 Go to the issue

Poster presentation

Changing antiretrovirals whilst viral load <50 copies/ml and relationship with CD4 count changes

Poster presentation

Therapeutic drug monitoring (TDM) of atazanavir in pregnancy

Poster presentation

SUPPORT: 48-week results of fosamprenavir/ritonavir vs efavirenz with abacavir/lamivudine in under-represented, antiretroviral-naïve patients

Poster presentation

A filter-based cross-sectional analysis of an HIV-positive, HAART-treated cohort in rural Burundi: pharmacokinetics, pharmacogenetics and viral load

Poster presentation

Metabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavir

Poster presentation

Analysis of determinants of long-term efficacy of unboosted atazanavir-based regimens in the clinical setting

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits